Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Priority claimed from PCT/US2013/049518external-prioritypatent/WO2014011520A1/en
Publication of MA37839A1publicationCriticalpatent/MA37839A1/en
L'invention concerne des immunoconjugués comprenant des anticorps anti-cd22 liés par covalence à un dérivé de némorubicine et des méthodes d'utilisation de ceux-ci.The present invention provides immunoconjugates comprising anti-cd22 antibodies covalently linked to a nemorubicin derivative and methods of use thereof.